EMEIS SA (EMEIS.PA) Fundamental Analysis & Valuation

EPA:EMEIS • FR001400NLM4

Current stock price

13.76 EUR
-0.54 (-3.78%)
Last:

This EMEIS.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. EMEIS.PA Profitability Analysis

1.1 Basic Checks

  • EMEIS had negative earnings in the past year.
  • In the past year EMEIS had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: EMEIS reported negative net income in multiple years.
  • EMEIS had a positive operating cash flow in each of the past 5 years.
EMEIS.PA Yearly Net Income VS EBIT VS OCF VS FCFEMEIS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

1.2 Ratios

  • EMEIS has a worse Return On Assets (-2.22%) than 81.82% of its industry peers.
  • EMEIS has a Return On Equity of -18.42%. This is in the lower half of the industry: EMEIS underperforms 78.79% of its industry peers.
  • The Return On Invested Capital of EMEIS (0.92%) is worse than 84.85% of its industry peers.
Industry RankSector Rank
ROA -2.22%
ROE -18.42%
ROIC 0.92%
ROA(3y)-7.04%
ROA(5y)-3.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EMEIS.PA Yearly ROA, ROE, ROICEMEIS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200 250

1.3 Margins

  • EMEIS has a worse Operating Margin (2.41%) than 78.79% of its industry peers.
  • In the last couple of years the Operating Margin of EMEIS has declined.
  • EMEIS does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 2.41%
PM (TTM) N/A
GM N/A
OM growth 3Y-79.31%
OM growth 5Y-64.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMEIS.PA Yearly Profit, Operating, Gross MarginsEMEIS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. EMEIS.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EMEIS is destroying value.
  • Compared to 1 year ago, EMEIS has more shares outstanding
  • Compared to 5 years ago, EMEIS has less shares outstanding
  • Compared to 1 year ago, EMEIS has a worse debt to assets ratio.
EMEIS.PA Yearly Shares OutstandingEMEIS.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
EMEIS.PA Yearly Total Debt VS Total AssetsEMEIS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 0.66, we must say that EMEIS is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.66, EMEIS is doing worse than 78.79% of the companies in the same industry.
  • The Debt to FCF ratio of EMEIS is 22.98, which is on the high side as it means it would take EMEIS, 22.98 years of fcf income to pay off all of its debts.
  • EMEIS has a Debt to FCF ratio of 22.98. This is in the lower half of the industry: EMEIS underperforms 69.70% of its industry peers.
  • A Debt/Equity ratio of 4.67 is on the high side and indicates that EMEIS has dependencies on debt financing.
  • EMEIS has a Debt to Equity ratio of 4.67. This is amonst the worse of the industry: EMEIS underperforms 81.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.67
Debt/FCF 22.98
Altman-Z 0.66
ROIC/WACC0.18
WACC5.22%
EMEIS.PA Yearly LT Debt VS Equity VS FCFEMEIS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 0.59 indicates that EMEIS may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.59, EMEIS is doing worse than 78.79% of the companies in the same industry.
  • EMEIS has a Quick Ratio of 0.59. This is a bad value and indicates that EMEIS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • EMEIS has a Quick ratio of 0.58. This is in the lower half of the industry: EMEIS underperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.58
EMEIS.PA Yearly Current Assets VS Current LiabilitesEMEIS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. EMEIS.PA Growth Analysis

3.1 Past

  • The earnings per share for EMEIS have decreased strongly by -136.45% in the last year.
  • The Revenue has been growing slightly by 6.30% in the past year.
  • The Revenue has been growing by 8.55% on average over the past years. This is quite good.
EPS 1Y (TTM)-136.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.96%
Revenue 1Y (TTM)6.3%
Revenue growth 3Y9.45%
Revenue growth 5Y8.55%
Sales Q2Q%4.92%

3.2 Future

  • EMEIS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.84% yearly.
  • EMEIS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.70% yearly.
EPS Next Y34.49%
EPS Next 2Y26.78%
EPS Next 3Y24.85%
EPS Next 5Y24.84%
Revenue Next Year5.51%
Revenue Next 2Y4.31%
Revenue Next 3Y4.34%
Revenue Next 5Y2.7%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EMEIS.PA Yearly Revenue VS EstimatesEMEIS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
EMEIS.PA Yearly EPS VS EstimatesEMEIS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 100 -100 200

More info and screens

Find the best growth stocksShow best growing peers

2

4. EMEIS.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • EMEIS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year EMEIS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EMEIS.PA Price Earnings VS Forward Price EarningsEMEIS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

  • 78.79% of the companies in the same industry are cheaper than EMEIS, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of EMEIS indicates a somewhat cheap valuation: EMEIS is cheaper than 72.73% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.37
EV/EBITDA 16.01
EMEIS.PA Per share dataEMEIS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • EMEIS's earnings are expected to grow with 24.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.78%
EPS Next 3Y24.85%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EMEIS.PA Dividend Analysis

5.1 Amount

  • EMEIS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EMEIS.PA Fundamentals: All Metrics, Ratios and Statistics

EMEIS SA

EPA:EMEIS (3/19/2026, 5:29:45 PM)

13.76

-0.54 (-3.78%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-28
Earnings (Next)04-07
Inst Owners59.73%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap2.22B
Revenue(TTM)5.77B
Net Income(TTM)-292.47M
Analysts46.67
Price Target14.18 (3.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.46%
PT rev (3m)2.96%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.54%
EPS NY rev (3m)9.2%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.38
P/FCF 6.37
P/OCF 3.7
P/B 1.4
P/tB N/A
EV/EBITDA 16.01
EPS(TTM)-1.79
EYN/A
EPS(NY)-0.88
Fwd EYN/A
FCF(TTM)2.16
FCFY15.71%
OCF(TTM)3.72
OCFY27.01%
SpS35.75
BVpS9.83
TBVpS-7.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.22%
ROE -18.42%
ROCE 1.34%
ROIC 0.92%
ROICexc 0.95%
ROICexgc 1.27%
OM 2.41%
PM (TTM) N/A
GM N/A
FCFM 6.05%
ROA(3y)-7.04%
ROA(5y)-3.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-77.23%
ROICexgc growth 5Y-61.49%
ROICexc growth 3Y-76.08%
ROICexc growth 5Y-60.94%
OM growth 3Y-79.31%
OM growth 5Y-64.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 4.67
Debt/FCF 22.98
Debt/EBITDA 12.85
Cap/Depr 57.36%
Cap/Sales 4.35%
Interest Coverage 250
Cash Conversion 104.05%
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.58
Altman-Z 0.66
F-Score5
WACC5.22%
ROIC/WACC0.18
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)5.82%
Cap/Sales(5y)13.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-136.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.96%
EPS Next Y34.49%
EPS Next 2Y26.78%
EPS Next 3Y24.85%
EPS Next 5Y24.84%
Revenue 1Y (TTM)6.3%
Revenue growth 3Y9.45%
Revenue growth 5Y8.55%
Sales Q2Q%4.92%
Revenue Next Year5.51%
Revenue Next 2Y4.31%
Revenue Next 3Y4.34%
Revenue Next 5Y2.7%
EBIT growth 1Y228.78%
EBIT growth 3Y-77.35%
EBIT growth 5Y-61.53%
EBIT Next Year10842.4%
EBIT Next 3Y416.71%
EBIT Next 5Y255.33%
FCF growth 1Y-30.08%
FCF growth 3YN/A
FCF growth 5Y14.58%
OCF growth 1Y139.56%
OCF growth 3Y-14.44%
OCF growth 5Y-10.16%

EMEIS SA / EMEIS.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of EMEIS SA (EMEIS.PA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to EMEIS.PA.


What is the valuation status of EMEIS SA (EMEIS.PA) stock?

ChartMill assigns a valuation rating of 2 / 10 to EMEIS SA (EMEIS.PA). This can be considered as Overvalued.


Can you provide the profitability details for EMEIS SA?

EMEIS SA (EMEIS.PA) has a profitability rating of 1 / 10.


What is the financial health of EMEIS SA (EMEIS.PA) stock?

The financial health rating of EMEIS SA (EMEIS.PA) is 0 / 10.


How sustainable is the dividend of EMEIS SA (EMEIS.PA) stock?

The dividend rating of EMEIS SA (EMEIS.PA) is 0 / 10 and the dividend payout ratio is 0%.